Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer

PURPOSE: The purpose of this study was to evaluate efficacy and toxicity of irinotecan, leucovorin and 5-fluorouracil (FOLFIRI) as second-line treatment after failure of oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) for advanced gastric cancer. MATERIALS AND METHODS: Patients who received modi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jeon, Eun Kyoung, Hong, Sook Hee, Kim, Tae Hee, Jung, Seung Eun, Park, Ji Chan, Won, Hye-Sung, Ko, Yoon-Ho, Rho, Sang Young, Hong, Young Seon
Format: Artigo
Idioma:Inglês
Publicat: Korean Cancer Association 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3192875/
https://ncbi.nlm.nih.gov/pubmed/22022291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2011.43.3.148
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars